Invasive Meningococcal Disease Clinical Trial
Official title:
IMPACT Project Protocol: Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada
Active metropolitan area surveillance for hospital admissions related to invasive infection with Neisseria meningitidis will be conducted at the 12 centers in the IMPACT network in collaboration with Public Health officials, local infection specialists and infection control practitioners during the interval from January 1, 2016 to December 31, 2022.
The objectives are 3-fold, including: 1. description of affected children and adults and the nature and outcome of the infection episodes 2. incidence rate determination in defined populations, by age, serogroup and study year 3. detailed study of the organisms recovered from cases ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01732627 -
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
|
Phase 2 | |
| Completed |
NCT01129518 -
Can we Reduce the Number of Vaccine Injections for Children?
|
Phase 4 | |
| Completed |
NCT01272180 -
Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults
|
Phase 2 |